Dr Nicholas Smith

2006 - PhD Biochemistry/Endocrinology, Queen Mary, University of London, UK

2002 - Post-graduate Certificate “Principles of Protein Structure”, Birkbeck, University of London, UK

2000 - BSc (Hons) Physiology, University of Bristol, UK

イギリス出身、ニュージーランド在住。エダンズ・グループのコンサルタント兼エディター。就任以前は、製薬産業向け医療教育サービスとして、世界的に認められた機関「メディクスインターナショナル」でシニア・メディカル・ライターとして、有名な製薬会社の様々な医療コミュニケーションプロジェクトを成功させ、医学・科学ライティング/コミュニケーションの膨大な経験を積む。ロンドン大学クィーン・メアリー校の細胞・分子科学研究所にて研究助手として主に糖尿病関連代謝疾患の生化学を中心とする研究に携わり博士研究を行う。博士論文のタイトルは、"The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance" 。
Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.